13 insiders reported 52 Form 4 transactions for Adverum Biotechnologies, Inc. (ADVM) over the past 18 months (most recent 2025-12-10). Recent activity: Svoronos Dawn (Director) Sell 5,000 shares, Scopa James Paul (Director) Sell 10,333 shares, Seyedkazemi Setareh (CHIEF DEVELOPMENT OFFICER) Sell 8,125 shares, Seyedkazemi Setareh (CHIEF DEVELOPMENT OFFICER) Buy 85,000 shares, Seyedkazemi Setareh (CHIEF DEVELOPMENT OFFICER) Sell 88,332 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-10 | Svoronos Dawn | Director | Sell | 5,000 | $0 |
| 2025-12-10 | Scopa James Paul | Director | Sell | 10,333 | $0 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Sell | 8,125 | $0 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Buy | 85,000 | $0 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Sell | 88,332 | $0 |
| 2025-12-10 | Ozden Rabia Gurses | Chief Medical Officer | Sell | 8,125 | $0 |
| 2025-12-10 | Ozden Rabia Gurses | Chief Medical Officer | Buy | 85,000 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Buy | 48,750 | $204,750 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Sell | 80,189 | $0 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Sell | 13,125 | $0 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Buy | 150,000 | $0 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Sell | 157,333 | $0 |
| 2025-12-10 | Machado Patrick | Director | Sell | 8,818 | $0 |
| 2025-12-10 | Lupher, Jr. Mark L. | Director | Sell | 13,000 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Buy | 150,000 | $630,000 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Sell | 351,513 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Sell | 25,000 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Buy | 500,000 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Sell | 522,666 | $0 |
| 2025-12-10 | Ozden Rabia Gurses | Chief Medical Officer | Sell | 85,000 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Sell | 61,150 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Sell | 8,125 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Buy | 42,000 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Sell | 42,000 | $0 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Sell | 54,874 | $0 |
Source: SEC Form 4 filings · as of 2025-12-10